Avid Bioservices, Inc.(CDMO),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

CDMO Avid Bioservices, Inc.

Closed 05-16 16:00:00 EDT

9.20

-0.05

-0.54%

盘后9.20

+0.000.00%

17:14 EDT

High9.47	Low8.90	Vol790.97K
Open9.23	D1 Closing9.25	Amplitude6.16%
Mkt Cap584.01M	Tradable Cap509.37M	Total Shares63.48M
T/O7.29M	T/O Rate1.43%	Tradable Shares55.37M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

{"stockData":{"symbol":"CDMO","market":"US","secType":"STK","nameCN":"Avid Bioservices, Inc.","latestPrice":9.2,"timestamp":1715889600000,"preClose":9.25,"halted":0,"volume":790972,"hourTrading":{"tag":"盘后","latestPrice":9.2,"preClose":9.2,"latestTime":"17:14 EDT","volume":27164,"amount":249894.15,"timestamp":1715894084784},"delay":0,"floatShares":55366549,"shares":63479794,"eps":-0.280812,"marketStatus":"Closed","change":-0.05,"latestTime":"05-16 16:00:00 EDT","open":9.23,"high":9.47,"low":8.9,"amount":7291421.142460001,"amplitude":0.061622,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.280812,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Market Trading","tradingStatus":1,"beginTime":1715932800000},"marketStatusCode":5,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":9.25,"postHourTrading":{"tag":"盘后","latestPrice":9.2,"preClose":9.2,"latestTime":"17:14 EDT","volume":27164,"amount":249894.15,"timestamp":1715894084784},"volumeRatio":0.661897},"requestUrl":"/m/hq/s/CDMO/","defaultTab":"news","newsList":[{"id":"2436984050","title":"Lifecore Biomedical Completes Incremental Liquidity Initiatives","url":"https://stock-news.laohu8.com/highlight/detail?id=2436984050","media":"GlobeNewswire","top":-1,"share":"https://ttm.financial/m/news/2436984050?lang=en_us&edition=fundamental","pubTime":"2024-05-16 20:45","pubTimestamp":1715863500,"startTime":"0","endTime":"0","summary":"Recent Initiatives Provide Approximately $8 Million of Non-Dilutive, Incremental Liquidity through Various Amendments with LendersCHASKA, Minn., May  16, 2024  (GLOBE NEWSWIRE) -- Lifecore Biomedical,","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/05/16/2883915/23089/en/Lifecore-Biomedical-Completes-Incremental-Liquidity-Initiatives.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2436981404","title":"Scorpius Holdings, Inc. Announces Closing of Public Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2436981404","media":"GlobeNewswire","top":-1,"share":"https://ttm.financial/m/news/2436981404?lang=en_us&edition=fundamental","pubTime":"2024-05-16 20:15","pubTimestamp":1715861700,"startTime":"0","endTime":"0","summary":"DURHAM, N.C., May  16, 2024  (GLOBE NEWSWIRE) -- Scorpius Holdings, Inc. (NYSE American: SCPX), (“Scorpius” or the “Company”), an integrated contract development and manufacturing organization (CDMO),","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/05/16/2883886/32418/en/Scorpius-Holdings-Inc-Announces-Closing-of-Public-Offering.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2435197676","title":"Avid Bioservices: A Unique Growth Story With Many Tailwinds And Catalysts","url":"https://stock-news.laohu8.com/highlight/detail?id=2435197676","media":"seekingalpha","top":-1,"share":"https://ttm.financial/m/news/2435197676?lang=en_us&edition=fundamental","pubTime":"2024-05-16 19:29","pubTimestamp":1715858988,"startTime":"0","endTime":"0","summary":"Although Avid is 30+ years old, the story has become much more exciting due to the shift to a pure-play biologics CDMO, pharma increasingly outsourcing biologics, and record revenue-generating capacit","market":"fut","thumbnail":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1291142737/image_1291142737.jpg","type":0,"news_type":0,"thumbnails":["https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1291142737/image_1291142737.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://seekingalpha.com/article/4693799-avid-bioservices-a-unique-growth-story-with-many-tailwinds-and-catalysts","is_publish_highlight":false,"gpt_icon":0},{"id":"2435963124","title":"Scorpius Holdings Achieves Major Milestone with cGMP Facility Validation for Microbial Manufacturing","url":"https://stock-news.laohu8.com/highlight/detail?id=2435963124","media":"GlobeNewswire","top":-1,"share":"https://ttm.financial/m/news/2435963124?lang=en_us&edition=fundamental","pubTime":"2024-05-15 12:00","pubTimestamp":1715745600,"startTime":"0","endTime":"0","summary":"Gaining operating efficiency through transition to an internal environmental monitoring teamDURHAM, N.C., May  15, 2024  (GLOBE NEWSWIRE) -- Scorpius Holdings, Inc (NYSE American: SCPX),(“Scorpius” or","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/05/15/2882385/32418/en/Scorpius-Holdings-Achieves-Major-Milestone-with-cGMP-Facility-Validation-for-Microbial-Manufacturing.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2435916405","title":"Press Release: Scorpius Holdings, Inc. Announces Pricing of Public Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2435916405","media":"Dow Jones","top":-1,"share":"https://ttm.financial/m/news/2435916405?lang=en_us&edition=fundamental","pubTime":"2024-05-14 19:15","pubTimestamp":1715685300,"startTime":"0","endTime":"0","summary":"DURHAM, N.C., May 14, 2024  -- Scorpius Holdings, Inc. , , an integrated contract development and manufacturing organization , today announced the pricing of its underwritten public offering of 60,000,000 common units and/or pre-funded units in lieu thereof. Each common  unit is being offered at a public offering price of $0.10 per unit  and consists of one share of common stock  and a common warrant to purchase one share of common stock. The common warrants will have an exercise price of $0.12 per share and will be immediately exercisable upon issuance for a period of five years following the date of issuance. The gross proceeds to the Company from the offering are expected to be approximately $6,000,000, before deducting underwriting discounts and offering expenses. In addition, the Company has granted the underwriters a 45-day option to purchase up to an additional 9,000,000 shares of common stock  and/or up to an additional 9,000,000 common warrants solely to cover over-allotments,","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"gpt_icon":1},{"id":"2435020803","title":"Donaldson and PolyPeptide Partner to Improve Sustainability in Peptide Manufacturing with Solvent Recovery Technology","url":"https://stock-news.laohu8.com/highlight/detail?id=2435020803","media":"Business Wire","top":-1,"share":"https://ttm.financial/m/news/2435020803?lang=en_us&edition=fundamental","pubTime":"2024-05-14 04:12","pubTimestamp":1715631120,"startTime":"0","endTime":"0","summary":"Companies’ combined ingenuity and desire for sustainability unite to solve an industry challenge. MINNEAPOLIS & TORRANCE, Calif., May 13, 2024----Donaldson Company, Inc. , a leading worldwide manufacturer of innovative filtration and separation products and solutions, and PolyPeptide Group AG , a global leader in peptide manufacturing, today announced their collaboration on the development of a production scale solvent recovery system for use in peptide purification. Peptides are used as the active pharmaceutical ingredient  in therapeutic areas, which continue to broaden and include metabolic disorders, oncology, infectious diseases, orphan diseases, cardiovascular, neurology or gastro-enterology applications.The collaboration between Donaldson and PolyPeptide marks a milestone in the pharmaceutical industry's pursuit of environmentally friendly manufacturing practices. By leveraging Donaldson's experience in filtration and separation technologies and PolyPeptide’s expertise in peptid","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/27G_3AoSDMCTbhNhSAJRuw--~B/aD01NzQ7dz0xNTQ5O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/ba84c370cb606cf46d9d59fd0d3e7a03","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/27G_3AoSDMCTbhNhSAJRuw--~B/aD01NzQ7dz0xNTQ5O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/ba84c370cb606cf46d9d59fd0d3e7a03"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/donaldson-polypeptide-partner-improve-sustainability-201200594.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2434622598","title":"Press Release: Piramal Pharma Limited Announces Results for Q4 and FY2024","url":"https://stock-news.laohu8.com/highlight/detail?id=2434622598","media":"Dow Jones","top":-1,"share":"https://ttm.financial/m/news/2434622598?lang=en_us&edition=fundamental","pubTime":"2024-05-11 01:45","pubTimestamp":1715363100,"startTime":"0","endTime":"0","summary":"MUMBAI, India, May 10, 2024 /PRNewswire/ -- Piramal Pharma Limited  , a leading global pharmaceuticals company, today announced its standalone and consolidated results for the Fourth Quarter  and Full Year  ended 31 March 2024.Revenue from Operations     2,552   2,164     18 %     8,171   7,082    15 %. CDMO                      1,649   1,281     29 %     4,750   4,001    19 %. Healthcare           238     210      14 %      985     874     13 %. EBITDA(#)                    556     376      48 %     1,372    853     61 %. EBITDA Margin                22 %    17 %               17 %   12 %. # FY2023 EBITDA had one-time inventory margin impact of INR 68 Crores. * Q4 FY24 Exceptional item of INR 31 Crores towards non-cash write down of. investment and license rights in relation to a certain third-party product no. -- Revenue from Operations grew by 18% YoY and 15% YoY in Q4FY24 and FY24. respectively, driven by healthy growth in our CDMO and I","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"gpt_icon":0},{"id":"2434105380","title":"Decoding Catalent Inc (CTLT): A Strategic SWOT Insight","url":"https://stock-news.laohu8.com/highlight/detail?id=2434105380","media":"GuruFocus.com","top":-1,"share":"https://ttm.financial/m/news/2434105380?lang=en_us&edition=fundamental","pubTime":"2024-05-09 13:05","pubTimestamp":1715231114,"startTime":"0","endTime":"0","summary":"Comprehensive SWOT analysis of Catalent Inc, revealing key strategic facets.Financial performance and market positioning of Catalent Inc dissected for investor awareness.Expert evaluation of Catalent Inc's operational dynamics and future prospects.Objective assessment of potential challenges and growth trajectories for Catalent Inc.GuruFocus has detected 11 Warning Signs with CTLT.Innovative Technologies and Expansion Initiatives: Catalent's investment in innovative technologies, such as Zydis fast-dissolve and biologics manufacturing capabilities, positions the company at the forefront of industry advancements. The acquisition of Metrics Contract Services, specializing in the manufacture of drugs containing highly potent active pharmaceutical ingredients, further expands Catalent's oral solid dosage capabilities. These strategic initiatives not only enhance the company's service offerings but also demonstrate its commitment to meeting evolving industry demands and maintaining technolo","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/sgSpZxA886HFKZKWf3LuLQ--~B/aD03ODQ7dz0xMjQyO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/us.finance.gurufocus/8a4745bc0f9796e6a1254ff93e74667e","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/sgSpZxA886HFKZKWf3LuLQ--~B/aD03ODQ7dz0xMjQyO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/us.finance.gurufocus/8a4745bc0f9796e6a1254ff93e74667e"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/decoding-catalent-inc-ctlt-strategic-050514598.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2434575776","title":"Hidden Gems: Unveiling the 10 Stocks on Hedge Funds’ Radar","url":"https://stock-news.laohu8.com/highlight/detail?id=2434575776","media":"Insider Monkey","top":-1,"share":"https://ttm.financial/m/news/2434575776?lang=en_us&edition=fundamental","pubTime":"2024-05-09 00:26","pubTimestamp":1715185581,"startTime":"0","endTime":"0","summary":"In this article we are going to reveal the names of 10 stocks that are on hedge funds' radar.The US market sustained strong performance in the first quarter of 2024 as the S&P Index increased by 10.6%, continuing its momentum from the previous quarter. There is a prevailing optimism in the market regarding a soft landing of the economy. The optimism over generative AI that contributed to the 2023 market rally is sustaining in 2024. The valuation of mega-cap companies significantly influences the S&P 500 Index. You can check out the best mega-cap stocks to buy according to hedge funds here.","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/3T8GK1.nhqyiws1UM36jug--~B/aD02MDA7dz00NzM7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/bfbc4793d965bf3521d25fb091d060db","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/3T8GK1.nhqyiws1UM36jug--~B/aD02MDA7dz00NzM7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/bfbc4793d965bf3521d25fb091d060db"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/hidden-gems-unveiling-10-stocks-162621984.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2433725462","title":"Craig-Hallum Sticks to Their Buy Rating for Avid Bioservices (CDMO)","url":"https://stock-news.laohu8.com/highlight/detail?id=2433725462","media":"TIPRANKS","top":-1,"share":"https://ttm.financial/m/news/2433725462?lang=en_us&edition=fundamental","pubTime":"2024-05-08 20:59","pubTimestamp":1715173179,"startTime":"0","endTime":"0","summary":"Craig-Hallum analyst Matt Hewitt maintained a Buy rating on Avid Bioservices (CDMO – Research Report) today. The company’s shares closed yesterday ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/craig-hallum-sticks-to-their-buy-rating-for-avid-bioservices-cdmo?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/craig-hallum-sticks-to-their-buy-rating-for-avid-bioservices-cdmo?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"gpt_icon":0},{"id":"2433020205","title":"Scorpius Holdings Appoints New VP of Business Development Shari Udoff-McDonald","url":"https://stock-news.laohu8.com/highlight/detail?id=2433020205","media":"GlobeNewswire","top":-1,"share":"https://ttm.financial/m/news/2433020205?lang=en_us&edition=fundamental","pubTime":"2024-05-07 20:30","pubTimestamp":1715085000,"startTime":"0","endTime":"0","summary":"Biopharma industry veteran joins Scorpius’ leadership team. DURHAM, N.C., May 07, 2024  -- Scorpius Holdings, Inc.  , an integrated contract development and manufacturing organization , today announced the appointment of Shari Udoff-McDonald as VP of Business Development. She brings more than 25 years of experience in biopharma business development and management.Prior to joining Scorpius, Ms. Udoff-McDonald spent 17 years at BioReliance Corporation, part of MilliporeSigma. She was most recently Head of Commercial, North America, East with interim oversight of half of the European market. Her role included commercial oversight of biologics, vaccines, cell and gene therapies, ADCs, and mRNA GMP testing services for sponsors and CDMOs.Joe Payne, Scorpius’ President and COO, said, “Shari has the unique combination of experience in the field, at the account-level, and in leadership roles. This wide breadth of business development experience will help Scorpius continue to grow its customer ","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/MYDQErgZBT4ZDUu5xu5Vsg--~B/aD0zMDA7dz00NjY7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/2accd018dfdbfa19ec5cf0cb04a7a33b","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/MYDQErgZBT4ZDUu5xu5Vsg--~B/aD0zMDA7dz00NjY7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/2accd018dfdbfa19ec5cf0cb04a7a33b"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/scorpius-holdings-appoints-vp-business-123000762.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2433732224","title":"Avid Bioservices to Participate at Upcoming Investor Conferences","url":"https://stock-news.laohu8.com/highlight/detail?id=2433732224","media":"GlobeNewswire","top":-1,"share":"https://ttm.financial/m/news/2433732224?lang=en_us&edition=fundamental","pubTime":"2024-05-07 20:05","pubTimestamp":1715083500,"startTime":"0","endTime":"0","summary":"Stephanie Diaz (Investors). Vida Strategic Partners. 415-675-7401. sdiaz@vidasp.com. Tim Brons (Media). Vida Strategic Partners. 415-675-7402. tbrons@vidasp.com","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/05/07/2877226/0/en/Avid-Bioservices-to-Participate-at-Upcoming-Investor-Conferences.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2433208670","title":"Integer to Showcase Strategic Investments to Support Customers’ Growth and Innovation at Heart Rhythm 2024","url":"https://stock-news.laohu8.com/highlight/detail?id=2433208670","media":"GlobeNewswire","top":-1,"share":"https://ttm.financial/m/news/2433208670?lang=en_us&edition=fundamental","pubTime":"2024-05-07 12:00","pubTimestamp":1715054400,"startTime":"0","endTime":"0","summary":"PLANO, Texas, May  07, 2024  (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE: ITGR), a leading medical device contract development and manufacturing organization (CDMO), will join medtech indus","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/05/07/2876641/26755/en/Integer-to-Showcase-Strategic-Investments-to-Support-Customers-Growth-and-Innovation-at-Heart-Rhythm-2024.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2433054004","title":"Avid Bioservices Currently Up 11 Consecutive Days, on Track for Longest Winning Streak on Record -- Data Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2433054004","media":"Dow Jones","top":-1,"share":"https://ttm.financial/m/news/2433054004?lang=en_us&edition=fundamental","pubTime":"2024-05-06 23:33","pubTimestamp":1715009580,"startTime":"0","endTime":"0","summary":"Avid Bioservices, Inc.  is currently at $8.37, up $0.12 or 1.45%. --Would be highest close since March 6, 2024, when it closed at $8.79. --Currently up 11 consecutive days; up 30.99% over this period. --Best 11 day stretch since the 11 days ending Dec. 28, 2023, when it rose 36.35%. --Down 98.29% from its all-time closing high of $490.00 on March 7, 2000. --Down 53.60% from 52 weeks ago , when it closed at $18.04. --Down 53.81% from its 52-week closing high of $18.12 on May 9, 2023. --Up 80.39% from its 52-week closing low of $4.64 on Dec. 8, 2023","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"gpt_icon":0},{"id":"2432294717","title":"How Novo-Catalent Deal Affects Halozyme (HALO)?","url":"https://stock-news.laohu8.com/highlight/detail?id=2432294717","media":"Insider Monkey","top":-1,"share":"https://ttm.financial/m/news/2432294717?lang=en_us&edition=fundamental","pubTime":"2024-05-03 16:17","pubTimestamp":1714724231,"startTime":"0","endTime":"0","summary":"Laughing Water Capital, an investment management company, released its first-quarter 2024 investor letter. A copy of the same can be downloaded here. In the first quarter, investment in the fund returned 8.4% after all fees and expenses compared to 10.6% and 5.2% returns for the SP500TR and R2000 during the quarter, respectively. In addition, you can check the top 5 holdings of the fund to know its best picks in 2024.Laughing Water Capital featured stocks like Halozyme Therapeutics, Inc.  in the first quarter 2024 investor letter. Based in San Diego, California, Halozyme Therapeutics, Inc.  is a biopharma technology company. On May 2, 2024, Halozyme Therapeutics, Inc.  stock closed at $39.82 per share. One-month return of Halozyme Therapeutics, Inc.  was -3.04%, and its shares gained 28.45% of their value over the last 52 weeks. Halozyme Therapeutics, Inc.  has a market capitalization of $5.059 billion.Halozyme Therapeutics, Inc.  is not on our list of30 Most Popular Stocks Among Hedge","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/rvMpxBU0aXOK3NVfIVFjlA--~B/aD00MzA7dz03Njg7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/92f0380d0c0a8bd65fa79d4dc22070ac","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/rvMpxBU0aXOK3NVfIVFjlA--~B/aD00MzA7dz03Njg7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/92f0380d0c0a8bd65fa79d4dc22070ac"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/novo-catalent-deal-affects-halozyme-081711085.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2432677687","title":"Charles River Launches Viral Vector Reference Materials to Streamline the Transition to GMP","url":"https://stock-news.laohu8.com/highlight/detail?id=2432677687","media":"Business Wire","top":-1,"share":"https://ttm.financial/m/news/2432677687?lang=en_us&edition=fundamental","pubTime":"2024-05-02 20:00","pubTimestamp":1714651200,"startTime":"0","endTime":"0","summary":"Supporting scale-up for early-phase AAV- and LVV-based gene and gene-modified cell therapy researchers and developers. Moving towards a gold standard for reference materials, Charles River is introducing six AAV reference material serotypes, offering superior empty and full capsid ratios and high vector genome concentration , plus five LVV reference material products, available with different combinations of promoters and reporter genes. The additional reference materials add to the Company’s extensive portfolio of plasmid and viral vector contract development and manufacturing organization  offerings, reinforcing its concept-to-cure commitment to CGT researchers and developers by enabling partners to navigate the path from early discovery to commercial.ASGCT LaunchCharles River will officially launch its AAV and LVV reference materials with supporting case study data during the American Society of Gene and Cell Therapy  Annual Meeting, May 7 – 11, 2024, in Baltimore, MD.Cell and Gene ","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/UQGjqAddApmBpz_jsGKe2g--~B/aD0zMjY7dz0xMjQ1O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/f0c3e20e1c8ea582ad37f70d0d64b610","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/UQGjqAddApmBpz_jsGKe2g--~B/aD0zMjY7dz0xMjQ1O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/f0c3e20e1c8ea582ad37f70d0d64b610"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/charles-river-launches-viral-vector-120000950.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2432390573","title":"Integer to Present at 2024 Bank of America Securities Healthcare Conference on May 14","url":"https://stock-news.laohu8.com/highlight/detail?id=2432390573","media":"GlobeNewswire","top":-1,"share":"https://ttm.financial/m/news/2432390573?lang=en_us&edition=fundamental","pubTime":"2024-05-01 20:00","pubTimestamp":1714564800,"startTime":"0","endTime":"0","summary":"PLANO, Texas, May 01, 2024  -- Integer Holdings Corporation , a leading medical device contract development and manufacturing organization , today announced participation in the 2024 Bank of America Securities Healthcare Conference, to be held May 14 – 16, 2024, in Las Vegas. Integer President and Chief Executive Officer Joseph Dziedzic is scheduled to present on Tuesday, May 14, at 10:40 a.m. PDT.About IntegerInteger Holdings Corporation  is one of the largest medical device contract development and manufacturing organizations  in the world, serving the cardiac rhythm management, neuromodulation, and cardio and vascular markets. As a strategic partner of choice to medical device companies and OEMs, the Company is committed to enhancing the lives of patients worldwide by providing innovative, high-quality products and solutions. The Company's brands include Greatbatch Medical, Lake Region Medical and Electrochem. Additional information is available atwww.integer.net.","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/p2t2G1tgcV_UVWHOcZEQ1A--~B/aD05NDM7dz0yMTUzO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/330a5b736e07b05c5c5e1b81145c68b5","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/p2t2G1tgcV_UVWHOcZEQ1A--~B/aD05NDM7dz0yMTUzO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/330a5b736e07b05c5c5e1b81145c68b5"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/integer-present-2024-bank-america-120000696.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2432930637","title":"Avid Bioservices Is Maintained at Outperform by RBC Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2432930637","media":"Dow Jones","top":-1,"share":"https://ttm.financial/m/news/2432930637?lang=en_us&edition=fundamental","pubTime":"2024-05-01 01:18","pubTimestamp":1714497480,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/CDMO/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  April 30, 2024 13:18 ET (17:18 GMT)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"gpt_icon":0},{"id":"2431342215","title":"Analysts’ Opinions Are Mixed on These Healthcare Stocks: Harmony Biosciences Holdings (HRMY), Decibel Cannabis Company (OtherDBCCF) and Avid Bioservices (CDMO)","url":"https://stock-news.laohu8.com/highlight/detail?id=2431342215","media":"TIPRANKS","top":-1,"share":"https://ttm.financial/m/news/2431342215?lang=en_us&edition=fundamental","pubTime":"2024-04-30 20:40","pubTimestamp":1714480827,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Harmony Biosciences Holdings (HRMY – Research Report), Decibel Ca...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-harmony-biosciences-holdings-hrmy-decibel-cannabis-company-otherdbccf-and-avid-bioservices-cdmo?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-harmony-biosciences-holdings-hrmy-decibel-cannabis-company-otherdbccf-and-avid-bioservices-cdmo?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.avidbio.com","stockEarnings":[{"period":"1week","weight":0.1038},{"period":"1month","weight":0.3603},{"period":"3month","weight":0.2013},{"period":"6month","weight":0.6667},{"period":"1year","weight":-0.469},{"period":"ytd","weight":0.4231}],"compareEarnings":[{"period":"1week","weight":0.0243},{"period":"1month","weight":0.0502},{"period":"3month","weight":0.0553},{"period":"6month","weight":0.1752},{"period":"1year","weight":0.2914},{"period":"ytd","weight":0.1146}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Avid Bioservices, Inc., a contract development and manufacturing organization, provides process development and current good manufacturing practices (CGMP) clinical and commercial manufacturing services of biologics for the biotechnology and biopharmaceutical industries. The company offers various services, including clinical and commercial drug substance manufacturing, bulk packaging, release and stability testing, and regulatory submission and support. It also provides various process development services, such as upstream and downstream development and optimization, analytical methods development, cell line development, testing, and characterization. The company was formerly known as Peregrine Pharmaceuticals, Inc. and changed its name to Avid Bioservices, Inc. in January 2018. Avid Bioservices, Inc. was incorporated in 1981 and is headquartered in Tustin, California.","yearOnYearQuotes":[{"month":1,"riseRate":0.633333,"avgChangeRate":0.252871},{"month":2,"riseRate":0.566667,"avgChangeRate":0.058259},{"month":3,"riseRate":0.466667,"avgChangeRate":-0.035156},{"month":4,"riseRate":0.4,"avgChangeRate":-0.032334},{"month":5,"riseRate":0.516129,"avgChangeRate":0.113932},{"month":6,"riseRate":0.433333,"avgChangeRate":0.011938},{"month":7,"riseRate":0.3,"avgChangeRate":0.025373},{"month":8,"riseRate":0.333333,"avgChangeRate":0.002245},{"month":9,"riseRate":0.366667,"avgChangeRate":-0.050651},{"month":10,"riseRate":0.366667,"avgChangeRate":-0.037904},{"month":11,"riseRate":0.533333,"avgChangeRate":0.068059},{"month":12,"riseRate":0.4,"avgChangeRate":0.024422}],"exchange":"NASDAQ","name":"Avid Bioservices, Inc.","nameEN":"Avid Bioservices, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Avid Bioservices, Inc.(CDMO),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Avid Bioservices, Inc.(CDMO) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Avid Bioservices, Inc.,CDMO,Avid Bioservices, Inc.股票,Avid Bioservices, Inc.股票老虎,Avid Bioservices, Inc.股票老虎国际,Avid Bioservices, Inc.行情,Avid Bioservices, Inc.股票行情,Avid Bioservices, Inc.股价,Avid Bioservices, Inc.股市,Avid Bioservices, Inc.股票价格,Avid Bioservices, Inc.股票交易,Avid Bioservices, Inc.股票购买,Avid Bioservices, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Avid Bioservices, Inc.(CDMO),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Avid Bioservices, Inc.(CDMO) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}